Publications
Web site Clinical References
Since 1991, Urologix’ strong reputation for scientific integrity has been supported by extensive basic science. Nearly 200 peer-reviewed clinical articles and presentations support the efficacy and safety of our products and our consistent clinical results.
Our clinical outcomes represent more than 2,200 patients treated with Cooled ThermoTherapy™ at many of the world’s leading medical institutions.
The following is a sampling of articles:
Peer Reviewed Journal Articles
Durability and General Efficacy
Long-Term Pooled Analysis of Multicenter Studies of Cooled Thermotherapy for Benign Prostatic Hyperplasia: Results at Three Months Through Four Years. Trock, M., et al., Urology, 63 (4) pp 716-721 April 2004 B.
Cooled Thermotherapy for The Treatment of Benign Prostatic Hyperplasia: Durability of Results Obtained with the Targis System. P. Miller, et al., Urology, 61 (5) pp. 1160-1165 June 2003.
Transurethral Microwave Therapy in 200 Patients with a Minimum Follow-Up of 2 Years: Urodynamic and Clinical Results. G. Thalmann, et al., Journal of Urology, Vol. 167, 2496-1502, June 2002.
A High Efficiency Microwave Thermoablation System in the Treatment of Benign Prostatic Hyperplasia: Results of a Randomized, Sham-Controlled, Prospective, Double-Blind, Multicenter Clinical Trial. T. Larson, et al., Urology, 51 (5), 731-742, June 1998.
A Novel Transurethral Microwave Thermoablation System to Treat Benign Prostatic Hyperplasia? Results of a Prospective Multicenter Clinical Trial. E. Ramsey, et al., The Journal of Urology, vol. 158, 112-119, July 1997.
Cooled ThermoTherapy vs. Medical Management
Targeted Transurethral Microwave Thermotherapy versus Alpha-Blockade in Benign Prostatic Hyperplasia: Outcomes at 18 Months. B. Djavan, et al, Urology, Vol. 57(1) pp. 66-70, January 2001.
Cost Consequences of Surveillance, Medical Management or Surgery for Benign Prostatic Hyperplasia. T. Chirikos, E. Sanford, Journal of Urology Vol. 155 (4) April 1996
Interstitial Temperature Mapping
Detailed Interstitial Temperature Mapping During Treatment with a New Transurethral Microwave Thermoblation System in Patients with Benign Prostatic Hyperplasia. T. Larson, J. Collins, A. C—rica, Journal of Urology, vol. 159, 258-264, January, 1998.
Urinary Retention
Efficacy of High-Energy Transurethral Microwave Thermotherapy in Alleviating Medically Refractory Urinary Retention Due to Benign Prostatic Hyperplasia. D. Kellner, et. al. Urology 64 (4) pp. 703-706, October 2004.
Transurethral Microwave Thermotherapy (TUMT) with the Targis System: A Single-Centre Study on 78 Patients with Acute Urinary Retention and Poor General Health. A. Berger, et al., European Urology 43 (2003) pp. 176-180
Microwave Thermotherapy in Patients with Chronic Urinary Retention. B. Djavan et. al., Techniques in Urology, 6(4), 278-281, December 2000.
High-Energy Transurethral Microwave Thermotherapy in Patients With Acute Urinary Retention Due to Benign Prostatic Hyperplasia. B. Djavan, C. Seitz, K. Ghawidel, A. Basharkhah, B. Bursa, S. Hruby, and M. Marberger, Urology, vol. 54 (1), 18-22, July 1999.
Abstracts
Cooled ThermoCath® Microwave Catheter
Continuing Results of a Multi-Center Trial of a New Generation Cooled TUMT for Benign Prostatic Hyperplasia, L. Mynderse, C. Roehrborn, et al. Presented at the 2007 AUA Annual Meeting.
